Inventor · disambiguated record
Mark Cornebise
Also filed as: CORNEBISE MARK
15 granted patents·18 pending applications·238 citations·filing 2000–2024
93Inventor score
Top patents by PatentIndex Score
33 records- 0197US12151995B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2023·Granted Nov 26, 2024·4 cites·30 claims
- 0297US10857105B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2019·Granted Dec 8, 2020·82 cites·30 claims
- 0396US10442756B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2017·Granted Oct 15, 2019·59 cites·24 claims
- 0496US10392341B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2018·Granted Aug 27, 2019·28 cites·28 claims
- 0594US11597698B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2021·Granted Mar 7, 2023·15 cites·24 claims
- 0694US11220476B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2019·Granted Jan 11, 2022·13 cites·22 claims
- 0794US11066355B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2020·Granted Jul 20, 2021·23 cites·30 claims
- 0887US12324859B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2020·Granted Jun 10, 2025·1 cites·11 claims
- 0981US12404232B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2021·Granted Sep 2, 2025·0 cites·15 claims
- 1080US12263248B2Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2019·Granted Apr 1, 2025·1 cites·15 claims
- 1179US12312293B2Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 1279US2025228777A1Compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2024·Application pending·0 cites
- 1378US7196112B2Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2004·Granted Mar 27, 2007·4 cites·87 claims
- 1473US6630503B1Cell adhesion inhibitorsBIOGEN INC·Filed 2000·Granted Oct 7, 2003·5 cites·7 claims
- 1568US7034043B2Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2003·Granted Apr 25, 2006·3 cites·5 claims
- 1668US2023027864A1Compositions and methods for delivery of agents to immune cellsMODERNATX INC·Filed 2022·Application pending·0 cites
- 1761US2019314291A1Compositions and methods for delivery of agents to immune cellsMODERNATX INC·Filed 2019·Application pending·0 cites
- 1860US2024207444A1Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 1960US2024216288A1Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2060US2025375389A1Lipid nanoparticle compositions comprising phospholipid derivatives and related usesMODERNATX INC·Filed 2023·Application pending·0 cites
- 2159US2024207374A1Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2259US2024226025A1Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemiaMODERNATX INC·Filed 2022·Application pending·0 cites
- 2357US2024189449A1Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiencyMODERNATX INC·Filed 2022·Application pending·0 cites
- 2457US2024226026A1Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2022·Application pending·0 cites
- 2556US2025049727A1Compositions for the delivery of payload molecules to airway epitheliumMODERNATX INC·Filed 2022·Application pending·0 cites
- 2655US2006166961A1Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 2754US2007066533A1Cell adhesion inhibitorsLEE WEN-CHERNG·Filed 2006·Application pending·0 cites
- 2853US2022402965A1Sterol analogs and uses thereofMODERNATX INC·Filed 2019·Application pending·0 cites
- 2952US2023000773A1Novel headgroup lipid compounds and compositions for intracellular delivery of therapeutic agentsMODERNATX INC·Filed 2020·Application pending·0 cites
- 3052US2023285310A1Compositions for the delivery of payload molecules to airway epitheliumMODERNATX INC·Filed 2021·Application pending·0 cites
- 3152US2025281419A1Lipid aminesMODERNATX INC·Filed 2022·Application pending·0 cites
- 3236US8268818B2Inhibitors of C-MET and uses thereofWANG TIANSHENG·Filed 2007·Granted Sep 18, 2012·0 cites·18 claims
- 3336US2011135603A1Inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Cornebise files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →